Head-to-Head

Immunovant, Inc. Common Stock vs. Moderna, Inc. Common Stock

IMVT

Immunovant, Inc. Common Stock

$29.04 +2.22%

VS MRNA

Moderna, Inc. Common Stock

$228.44 +3.45%

Moderna, Inc. Common Stock (MRNA) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

IMVTMRNA
Market Cap $5.87 billion $88.16 billion

MRNA leads on 1 of 1 size & scale factors.

Risk & Sentiment

IMVTMRNA
Short Interest 0.15% 0.01%

MRNA leads on 1 of 1 risk & sentiment factors.

Dig deeper: IMVT overview, IMVT financials, MRNA overview, MRNA financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.